Retained Licenses Clause Samples

The Retained Licenses clause defines the rights that a party continues to hold or exercise over certain intellectual property, even after transferring or licensing it to another party. Typically, this clause specifies which uses, fields, or territories the original owner may still exploit, such as retaining the right to use a patented technology for internal research or non-commercial purposes. Its core function is to clarify the scope of rights that remain with the original owner, preventing misunderstandings and ensuring both parties know the boundaries of their respective rights.
Retained Licenses. AT&T PCS and its Affiliates may use the AT&T Retained Licenses, and may market and sell to their customers or others any services that use such Licenses permitted under applicable Laws, in each case as it may determine, and may otherwise deal with and permit others to deal with the AT&T Retained Licenses, except from and after the Closing Date to the extent otherwise expressly agreed by any AT&T Party in any of the Related Agreements.
Retained Licenses. The license granted in Section 3.1 and any license to be granted under Section 3.2 above are further conditional upon and subject to a right and license retained by Emory on behalf of itself and Emory research collaborators to make, use and transfer (not for value) Licensed Products and practice Licensed Technology for research and educational purposes only. Emory shall not undertake to make, use or transfer Licensed Products or practice Licensed Technology under the sponsorship of any for profit entity, other than AtheroGenics, without the express written approval of AtheroGenics. Emory shall have the right to publish the general scientific findings from research related to Licensed Patents and Licensed Technology subject to thirty (30) days prior review by AtheroGenics. Emory shall, upon AtheroGenics' request, delete any AtheroGenics' confidential information disclosed in such proposed publication. Emory shall also, upon the request of AtheroGenics made within that thirty (30) day period, refrain from making such publication for a period of time not to exceed ninety (90) days from the date of the request, in order to afford Emory, or AtheroGenics, as applicable, an opportunity to file a United States patent application to protect patentable subject matter disclosed in such proposed publication.
Retained Licenses. Notwithstanding the license grants set forth in this Section F.1 or elsewhere in this Agreement, GNE retains a non-assignable (except as provided in Section 16.3) right under the GNE Patents and GNE Know-how solely for purposes of performing in vitro research and Development activities with respect to IGF-I in the Field. For clarity, nothing in this Section F.1(e) is intended to create a right for GNE to sell, offer for sale, market or promote any product containing IGF-I in the Field.
Retained Licenses. Notwithstanding anything to the contrary in Schedule 1.1(a)(i) or this Schedule 1.1(a)(ii), all Accounts Receivable of Seller for sales of marijuana in the ordinary course of business via the Purchased Licenses prior to Closing.
Retained Licenses. PRF retains on behalf of itself, Purdue University, and any research collaborators, a royalty-free right and license under the Licensed Patent(s) for research and educational purposes only.

Related to Retained Licenses

  • Inbound Licenses Except as disclosed on the Schedule, Borrower is not a party to, nor is bound by, any license or other agreement that prohibits or otherwise restricts Borrower from granting a security interest in Borrower’s interest in such license or agreement or any other property.

  • Outbound Licenses Part 2.7(d) of the Disclosure Schedule accurately identifies each Contract pursuant to which any Person has been granted any license under, or otherwise has received or acquired any right (whether or not currently exercisable) or interest in, any Seller IP. The Seller is not bound by, and no Seller IP is subject to, any Contract containing any covenant or other provision that in any way limits or restricts the ability of the Seller to use, exploit, assert, or enforce any Seller IP anywhere in the world.

  • Permits and Licenses The Contractor shall observe and comply with all laws, rules, and regulations affecting services under this Agreement. The Contractor shall procure and keep in full force and effect during the term of this Agreement all permits and licenses necessary to accomplish the Work contemplated in this Agreement.

  • Licenses or Permits The Company and each of its subsidiaries possess all licenses, certificates, authorizations and permits issued by, and have made all declarations and filings with, the appropriate local, state, federal or foreign governmental or regulatory agencies or bodies (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA) that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described in the Registration Statement, the General Disclosure Package and the Prospectus (collectively, the “Governmental Permits”) except where any failures to possess or make the same would not, singularly or in the aggregate, have a Material Adverse Effect. The Company and its subsidiaries are in compliance with all such Governmental Permits; all such Governmental Permits are valid and in full force and effect, except where the invalidity or failure to be in full force and effect would not, singularly or in the aggregate, have a Material Adverse Effect. Neither the Company nor any subsidiary has received notification of any revocation, modification, suspension, termination or invalidation (or proceedings related thereto) of any such Governmental Permit and the Company has no reason to believe that any such Governmental Permit will not be renewed.

  • Permits, Licenses, Etc Each of the Borrower and its Subsidiaries possesses all permits, licenses, patents, patent rights or licenses, trademarks, trademark rights, trade names rights, and copyrights which are material to the conduct of its business. Each of the Borrower and its Subsidiaries manages and operates its business in accordance with all applicable Legal Requirements except where the failure to so manage or operate could not reasonably be expected to result in a Material Adverse Change; provided that this Section 4.14 does not apply with respect to Environmental Permits.